Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5258]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1...
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or PD-L1 inhibitor: initial results of LEAP-004 ( Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain )
22 Sep 2020
Osimertinib adjuvant therapy in patients with early stage EGFR mutated NSCLC...
Dr Masahito Tsuboi - National Cancer Center Hospital, Tokyo, Japan
Osimertinib adjuvant therapy in patients with early stage EGFR mutated NSCLC after tumour resection ( Dr Masahito Tsuboi - National Cancer Center Hospital, Tokyo, Japan )
22 Sep 2020
Latest updates to the ESMO bone health guidelines
Prof Robert Coleman - University of Sheffield, Sheffield, UK
Latest updates to the ESMO bone health guidelines ( Prof Robert Coleman - University of Sheffield, Sheffield, UK )
22 Sep 2020
Amivantamab lazertinib and other novel combinations in EGFR positive advanced...
Dr Alex Spira and Dr Joshua Sabari
Amivantamab lazertinib and other novel combinations in EGFR positive advanced NSCLC ( Dr Alex Spira and Dr Joshua Sabari )
21 Sep 2020
MonarchE: Abemaciclib plus endocrine therapy in high-risk early breast cancer
Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK
MonarchE: Abemaciclib plus endocrine therapy in high-risk early breast cancer ( Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK )
21 Sep 2020
Personalised molecularly matched therapies for carcinomas of unknown primary
Dr Jacob Adashek - University of South Florida, Tampa, USA
Personalised molecularly matched therapies for carcinomas of unknown primary ( Dr Jacob Adashek - University of South Florida, Tampa, USA )
21 Sep 2020
SOLO-1: Olaparib or placebo for patients with newly diagnosed BRCA-mutated...
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
SOLO-1: Olaparib or placebo for patients with newly diagnosed BRCA-mutated advanced ovarian cancer ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
20 Sep 2020
Comparing real world evidence to phase III data on apalutamide for nmCRPC
Prof Heather Payne and Prof Stéphane Oudard
Comparing real world evidence to phase III data on apalutamide for nmCRPC ( Prof Heather Payne and Prof Stéphane Oudard )
19 Sep 2020
Pembrolizumab vs cetuximab with radiotherapy in locally advanced HNSCC
Dr Yungan Tao - Gustave Roussy Cancer Campus, Villejuif, France
Pembrolizumab vs cetuximab with radiotherapy in locally advanced HNSCC ( Dr Yungan Tao - Gustave Roussy Cancer Campus, Villejuif, France )
19 Sep 2020
The emerging importance of studying immune regulatory molecule expression...
Dr Jacob Adashek - The University of South Florida, Tampa, USA
The emerging importance of studying immune regulatory molecule expression patterns ( Dr Jacob Adashek - The University of South Florida, Tampa, USA )
19 Sep 2020
OncoAlert and ecancer weekly roundup for September 6-13, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for September 6-13, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
14 Sep 2020
OncoAlert and ecancer weekly roundup for August 30 - September 5 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for August 30 - September 5 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
7 Sep 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation